Chrono Therapeutics

company

About

Chrono Therapeutics was founded by Guy DiPierro to cause a paradigm shift in the way addictions and diseases are treated.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.30M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2004
Number Of Employee
11 - 50
Operating Status
Active

Chrono Therapeutics (CHRONO) is a pharmaceutical company founded in 2004 with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) that offers real-time behavioral support. Chrono’s executive leadership combines years of professional experience and personal passions for developing life-saving medical products. Steeped with years of experience in product development, science, R&D an understanding of the consumer smoking cessation market, FDA approval experience and bringing life-saving products to market, the team represents a wide-array of knowledge that combined can help address the serious epidemic of smoking.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.30M
Chrono Therapeutics has raised a total of $2.30M in funding over 2 rounds. Their latest funding was raised on Aug 26, 2015 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 26, 2015 Grant $2.30M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Chrono Therapeutics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant